Clinical trial · Observational

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Collaborative Project on Potential Serum Markers for Malignant Melanoma, Metastatic Breast, Advanced Lung Pancreatic Carcinoma and Colorectal Cancer

NCT00974610CI-TRIAL-00027759completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in peptides and proteins and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood samples from patients with malignant melanoma, metastatic breast cancer, advanced lung cancer, pancreatic cancer, or colorectal cancer.

Conditions

Conditions (5)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Breast Cancer	Malignant Breast Neoplasm	CURATED_EXACT	0.92
Colorectal Cancer	Malignant Colorectal Neoplasm	CURATED_BROADER	0.80
Lung Cancer	Malignant Lung Neoplasm	CURATED_EXACT	0.92
Melanoma (Skin)	Melanoma	ONTOLOGY_EXACT	0.85
Pancreatic Cancer	Malignant Pancreatic Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Design

Arms and outcomes

Arms (5)

label
Breast
label
Lung
label
Melanoma
label
Pancreatic
label
Colorectal

Primary outcomes (1)

measure
Detection of peptide and protein markers in serum
timeFrame
Ongoing

Secondary outcomes (1)

measure
Identification of the protein/peptide involved
timeFrame

Eligibility

Eligibility (as posted)

Sex: All

Show eligibility criteria text

DISEASE CHARACTERISTICS:

* Diagnosis of 1 of the following advanced metastatic malignancies:

  * Malignant melanoma
  * Lung cancer
  * Breast cancer
  * Pancreatic carcinoma
  * Colorectal cancer
* Advanced and/or metastatic disease
* Hormone receptor status not specified

PATIENT CHARACTERISTICS:

* Menopausal status not specified

PRIOR CONCURRENT THERAPY:

* Not specified

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Aug 1, 2008
Primary completion: Dec 1, 2015
Completion: Jan 1, 2017
First posted: Sep 10, 2009
Last update posted: May 24, 2017
Enrollment: 803 (actual)
Lead sponsor: Cancer Trials Ireland NETWORK
Keywords: stage IV melanoma, recurrent melanoma, stage IV non-small cell lung cancer, recurrent non-small cell lung cancer, extensive stage small cell lung cancer, recurrent small cell lung cancer, stage IV breast cancer, recurrent breast cancer, male breast cancer, stage III pancreatic cancer, stage IV pancreatic cancer, recurrent pancreatic cancer, stage IV colon cancer, recurrent colon cancer, stage IV rectal cancer, recurrent rectal cancer

Data updated 22 days agoSource updated May 24, 2017source: clinicaltrials

Locations

Locations by country (13)

Country	Sites	Recruiting
Ireland	13	0

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.